Alpha-1-antitrypsin deficiency. 3: Clinical manifestations and natural history

Michelle Needham; Robert Stockley

Alpha-1-antitrypsin deficiency. 3: Clinical manifestations and natural history

Michelle Needham, Robert Stockley

Birmingham Medical School

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.

Original language	English
Title of host publication	Thorax
Volume	59(5)
Publication status	Published - 1 Jan 2004

Cite this

@inbook{909f464843fc49418ad94622dcac685a,

title = "Alpha-1-antitrypsin deficiency. 3: Clinical manifestations and natural history",

abstract = "A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.",

author = "Michelle Needham and Robert Stockley",

year = "2004",

month = jan,

day = "1",

language = "English",

volume = "59(5)",

booktitle = "Thorax",

}

TY - CHAP

T1 - Alpha-1-antitrypsin deficiency. 3: Clinical manifestations and natural history

AU - Needham, Michelle

AU - Stockley, Robert

PY - 2004/1/1

Y1 - 2004/1/1

N2 - A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.

AB - A review of the clinical manifestations of alpha(1)-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.

M3 - Chapter

VL - 59(5)

BT - Thorax

ER -

Alpha-1-antitrypsin deficiency. 3: Clinical manifestations and natural history

Abstract

Fingerprint

Cite this